Earnings Call · Q3 FY2022·2022-11-10

Q3 22EPS +18.75%·Rev n/aQ2 22EPS -16.00%·Rev n/aQ1 22EPS 0.00%·Rev n/aQ4 21EPS -36.84%·Rev n/a⚠ consensus missing

CAPRICOR THERAPEUTICS, INC. CAPR

AJ Bergmann — Chief Financial Officer

Linda Marbán — Chief Executive Officer

+4.0%1d on move date−1.5% vs SPY3d−12.1%5d−15.5%

Research tier

Behavioral profile computed for 2 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more CAPR calls or request research access.

More CAPR calls Browse calls Request research access